{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T19:31:50Z","timestamp":1761852710676,"version":"build-2065373602"},"reference-count":13,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","pathologyjournal.rcpa.edu.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology"],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1097\/pat.0000000000000030","type":"journal-article","created":{"date-parts":[[2013,12,3]],"date-time":"2013-12-03T10:58:21Z","timestamp":1386068301000},"page":"75-77","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Chronic myeloid leukaemia masquerading as primary myelofibrosis"],"prefix":"10.1016","volume":"46","author":[{"given":"Muhajir","family":"Mohamed","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Beamish","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julian","family":"Grabek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1097\/PAT.0000000000000030_bib0005","first-page":"1128","article-title":"European consensus on grading bone marrow fibrosis and assessment of cellularity","volume":"90","author":"Thiele","year":"2005","journal-title":"Haematologica"},{"key":"10.1097\/PAT.0000000000000030_bib0010","first-page":"1367","article-title":"Myelofibrosis in chronic myeloproliferative disorders-dynamics and clinical impact","volume":"21","author":"Thiele","year":"2006","journal-title":"Histol Histopathol"},{"key":"10.1097\/PAT.0000000000000030_bib0015","doi-asserted-by":"crossref","first-page":"2444","DOI":"10.1038\/sj.leu.2403172","article-title":"Marrow fibrosis, indicator of therapy failure in chronic myeloid leukemia - prospective long-term results from a randomized-controlled trial","volume":"17","author":"Buesche","year":"2003","journal-title":"Leukemia"},{"key":"10.1097\/PAT.0000000000000030_bib0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/ajcp\/82.1.1","article-title":"Transformation of chronic myelogenous leukemia: clinical, morphologic, and cytogenetic features","volume":"82","author":"Muehleck","year":"1984","journal-title":"Am J Clin Pathol"},{"key":"10.1097\/PAT.0000000000000030_bib0025","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1093\/ajcp\/101.4.426","article-title":"CD34 immunostaining of bone marrow biopsy specimens is a reliable way to classify the phases of chronic myeloid leukemia","volume":"101","author":"Orazi","year":"1994","journal-title":"Am J Clin Pathol"},{"key":"10.1097\/PAT.0000000000000030_bib0030","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1002\/cncr.20380","article-title":"Imatinib mesylate therapy reduces bone marrow fibrosis in patients with chronic myelogenous leukemia","volume":"101","author":"Bueso-Ramos","year":"2004","journal-title":"Cancer"},{"key":"10.1097\/PAT.0000000000000030_bib0035","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0022-3565(24)38879-2","article-title":"Abl protein-tyrosine kinase inhibitor STI571 inhibits in vitro signal transduction mediated by c-kit and platelet-derived growth factor receptors","volume":"295","author":"Buchdunger","year":"2000","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1097\/PAT.0000000000000030_bib0040","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1172\/JCI200419603","article-title":"Imatinib mesylate inhibits the profibrogenic activity of TGF-beta and prevents bleomycin-mediated lung fibrosis","volume":"114","author":"Daniels","year":"2004","journal-title":"J Clin Invest"},{"key":"10.1097\/PAT.0000000000000030_bib0045","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1002\/cncr.21235","article-title":"Significance of myelofibrosis in early chronic-phase, chronic myelogenous leukemia on imatinib mesylate therapy","volume":"104","author":"Kantarjian","year":"2005","journal-title":"Cancer"},{"key":"10.1097\/PAT.0000000000000030_bib0050","unstructured":"Turhan AG. Chronic myelogenous leukaemia (CML). Atlas Genet Cytogenet Oncol Haematol. August 2008; cited June 2013. http:\/\/AtlasGeneticsOncology.org\/Anomalies\/CML.html"},{"key":"10.1097\/PAT.0000000000000030_bib0055","first-page":"702831","article-title":"A case of Philadelphia chromosome positive myeloproliferative neoplasm in a pregnant woman with unusual primary myelofibrosis features","volume":"2013","author":"Koshy","year":"2013","journal-title":"Case Rep Hematol"},{"key":"10.1097\/PAT.0000000000000030_bib0060","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.leukres.2007.08.001","article-title":"A case of Philadelphia-chromosome positive chronic idiopathic myelofibrosis","volume":"32","author":"Chen","year":"2008","journal-title":"Leuk Res"},{"key":"10.1097\/PAT.0000000000000030_bib0065","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/j.leukres.2009.01.034","article-title":"A myeloproliferative disorder may hide another one","volume":"33","author":"Laibe","year":"2009","journal-title":"Leuk Res"}],"container-title":["Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031302516306481?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031302516306481?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T16:19:36Z","timestamp":1758471576000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0031302516306481"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1]]},"references-count":13,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,1]]}},"alternative-id":["S0031302516306481"],"URL":"https:\/\/doi.org\/10.1097\/pat.0000000000000030","relation":{},"ISSN":["0031-3025"],"issn-type":[{"type":"print","value":"0031-3025"}],"subject":[],"published":{"date-parts":[[2014,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chronic myeloid leukaemia masquerading as primary myelofibrosis","name":"articletitle","label":"Article Title"},{"value":"Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1097\/PAT.0000000000000030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Royal College of Pathologists of Australasia. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}